Egalet Corporation (NASDAQ:EGLT) Files An 8-K Entry into a Material Definitive AgreementItem 1.01 Entry into a Material Definitive Agreement.
On February 28, 2017, Egalet Corporation (the Company) and its wholly-owned subsidiaries, Egalet Ltd. and Egalet US Inc. (collectively with the Company, Egalet), entered into a Drug Product Manufacturing Services Agreement (the Agreement) with Halo Pharmaceutical, Inc. (Halo) to which Egalet engaged Halo to provide certain services related to the manufacture and supply of ARYMOTM ER tablets (the Product) for the Companys commercial use in the United States.
Egalet is obligated to purchase all of its requ…
Read the full article at: https://marketexclusive.com/egalet-corporation-nasdaqeglt-files-an-8-k-entry-into-a-material-definitive-agreement/79583/
